1. Home
  2. CUE vs SOTK Comparison

CUE vs SOTK Comparison

Compare CUE & SOTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CUE
  • SOTK
  • Stock Information
  • Founded
  • CUE 2014
  • SOTK 1975
  • Country
  • CUE United States
  • SOTK United States
  • Employees
  • CUE N/A
  • SOTK N/A
  • Industry
  • CUE Biotechnology: Pharmaceutical Preparations
  • SOTK Industrial Machinery/Components
  • Sector
  • CUE Health Care
  • SOTK Technology
  • Exchange
  • CUE Nasdaq
  • SOTK Nasdaq
  • Market Cap
  • CUE 64.4M
  • SOTK 67.7M
  • IPO Year
  • CUE 2018
  • SOTK 1987
  • Fundamental
  • Price
  • CUE $1.25
  • SOTK $4.47
  • Analyst Decision
  • CUE Strong Buy
  • SOTK Buy
  • Analyst Count
  • CUE 5
  • SOTK 1
  • Target Price
  • CUE $5.00
  • SOTK $10.00
  • AVG Volume (30 Days)
  • CUE 971.4K
  • SOTK 7.0K
  • Earning Date
  • CUE 11-14-2024
  • SOTK 10-15-2024
  • Dividend Yield
  • CUE N/A
  • SOTK N/A
  • EPS Growth
  • CUE N/A
  • SOTK 85.72
  • EPS
  • CUE N/A
  • SOTK 0.09
  • Revenue
  • CUE $9,532,000.00
  • SOTK $20,650,571.00
  • Revenue This Year
  • CUE $104.81
  • SOTK $6.08
  • Revenue Next Year
  • CUE N/A
  • SOTK $12.36
  • P/E Ratio
  • CUE N/A
  • SOTK $49.66
  • Revenue Growth
  • CUE 149.53
  • SOTK 25.27
  • 52 Week Low
  • CUE $0.45
  • SOTK $3.50
  • 52 Week High
  • CUE $3.25
  • SOTK $6.12
  • Technical
  • Relative Strength Index (RSI)
  • CUE 43.10
  • SOTK 56.29
  • Support Level
  • CUE $1.32
  • SOTK $4.21
  • Resistance Level
  • CUE $1.99
  • SOTK $4.50
  • Average True Range (ATR)
  • CUE 0.29
  • SOTK 0.15
  • MACD
  • CUE -0.06
  • SOTK 0.00
  • Stochastic Oscillator
  • CUE 0.67
  • SOTK 89.41

About CUE Cue Biopharma Inc.

Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune disease with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103 and others.

About SOTK Sono-Tek Corporation

Sono-Tek Corp designs and manufactures ultrasonic coating systems that apply precise, thin film coatings to a multitude of products for the microelectronics/electronics, alternative energy, medical, and industrial markets, including specialized glass applications in construction and automotive. It sells products to emerging research and development and other markets. Its ultrasonic nozzle systems use high-frequency, ultrasonic vibrations that atomize liquids into minute drops that can be applied to surfaces at low velocity providing thin layers of protective materials over a surface such as glass or metals.

Share on Social Networks: